Cabaletta Bio reported net income of -$51.02M for the quarter ended Jun 2026. This income statement covers 31 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 24.97M | 27.73M | 28.93M | 28.98M | 29.01M | 29.01M | 5.94M | 4.13M | 4.13M | 2.35M | 1.17M | 48.25M | 48.29M | 48.85M | 50.74M | 50.74M | 61.88M | 96.27M | 79.90M | 169.55M | |||||||||||
| Operating items | |||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 7.85M | 8.17M | 9.92M | 9.17M | 9.51M | 8.22M | 12.40M | 12.44M | 11.80M | 13.79M | 17.41M | 21.95M | 23.43M | 26.29M | 23.00M | 29.02M | 37.64M | 39.82M | 36.19M | 44.43M | |||||||||||
| Selling, General & AdministrativeSG&A | 3.29M | 3.39M | 3.97M | 3.83M | 3.55M | 3.56M | 3.90M | 4.52M | 4.09M | 4.88M | 5.74M | 6.08M | 6.85M | 6.76M | 8.25M | 8.12M | 8.27M | 6.76M | 6.42M | 7.59M | |||||||||||
| Other Operating ExpensesOther Opex | -0.06M | 0.50M | -0.08M | -0.08M | |||||||||||||||||||||||||||
| Operating ExpensesOpex | 11.14M | 11.56M | 13.89M | 13.00M | 13.06M | 11.78M | 16.30M | 16.96M | 15.89M | 18.67M | 23.15M | 28.03M | 30.28M | 33.05M | 33.78M | 37.14M | 45.91M | 46.59M | 42.61M | 52.02M | |||||||||||
| Operating IncomeOp. Inc | -11.14M | -11.56M | -13.89M | -13.00M | -13.06M | -11.78M | -16.30M | -16.96M | -15.89M | -18.67M | -23.15M | -28.03M | -30.28M | -33.05M | -33.78M | -37.14M | -45.91M | -46.59M | -42.61M | -52.02M | |||||||||||
| EBIT | -11.14M | -11.56M | -13.89M | -13.00M | -13.06M | -11.78M | -16.30M | -16.96M | -15.89M | -18.67M | -23.15M | -28.03M | -30.28M | -33.05M | -33.78M | -37.14M | -45.91M | -46.59M | -42.61M | -52.02M | |||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.75M | 0.29M | 0.57M | 0.58M | 0.56M | 0.52M | |||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.01M | 0.00M | 0.01M | 0.05M | 0.15M | 0.35M | 0.61M | 1.10M | 1.40M | 2.22M | 2.26M | 2.98M | 2.68M | 2.42M | 1.95M | 1.49M | 1.41M | 1.81M | 1.33M | 1.60M | |||||||||||
| Net income details | |||||||||||||||||||||||||||||||
| EBT | -11.14M | -11.56M | -13.89M | -12.95M | -12.91M | -11.43M | -15.69M | -15.85M | -14.49M | -16.45M | -20.89M | -25.05M | -27.60M | -30.63M | -32.59M | -35.94M | -45.07M | -45.36M | -41.84M | -50.93M | |||||||||||
| Profit After TaxPAT | -11.14M | -11.56M | -13.88M | -12.95M | -12.91M | -11.43M | -15.53M | -15.85M | -14.49M | -16.47M | -20.86M | -25.05M | -27.60M | -30.63M | -32.59M | -35.94M | -45.13M | -44.87M | -41.92M | -51.02M | |||||||||||
| Income from Continuing OperationsIncome (Continuing) | -11.14M | -11.56M | -13.89M | -12.95M | -12.91M | -11.43M | -15.69M | -15.85M | -14.49M | -16.45M | -20.89M | -25.05M | -27.60M | -30.63M | -32.59M | -35.94M | -45.07M | -45.36M | -41.84M | -50.93M | |||||||||||
| Consolidated Net IncomeConsol Net Inc. | -11.14M | -11.56M | -13.89M | -12.95M | -12.91M | -11.43M | -15.69M | -15.85M | -14.49M | -16.45M | -20.89M | -25.05M | -27.60M | -30.63M | -32.59M | -35.94M | -45.07M | -45.36M | -41.84M | -50.93M | |||||||||||
| Income towards Parent CompanyParent Net Inc | -11.14M | -11.56M | -13.89M | -12.95M | -12.91M | -11.43M | -15.69M | -15.85M | -14.49M | -16.45M | -20.89M | -25.05M | -27.60M | -30.63M | -32.59M | -35.94M | -45.07M | -45.36M | -41.84M | -50.93M | |||||||||||
| Net Income towards Common StockholdersNet Income | -11.14M | -11.56M | -13.89M | -12.95M | -12.91M | -11.43M | -15.69M | -15.85M | -14.49M | -16.45M | -20.89M | -25.05M | -27.60M | -30.63M | -32.59M | -35.94M | -45.07M | -45.36M | -41.84M | -50.93M | |||||||||||
| Additional items | |||||||||||||||||||||||||||||||
| EPS (Basic) | -0.45 | -0.45 | -0.54 | -0.45 | -0.45 | -0.39 | -2.64 | -3.84 | -3.51 | -7.01 | -17.88 | -0.50 | -0.56 | -0.62 | -0.66 | -0.71 | -0.73 | -0.44 | -0.52 | -0.34 | |||||||||||
| EPS (Diluted) | -0.38 | -0.38 | -0.46 | -0.39 | -0.40 | -0.35 | -0.48 | -0.42 | -0.35 | -0.36 | -0.49 | -0.49 | -0.55 | -0.62 | -0.65 | -0.72 | -0.73 | -0.73 | -0.68 | -0.34 | |||||||||||
| Shares Outstanding | 24.73M | 25.85M | 25.74M | 28.96M | 28.99M | 29.01M | 5.94M | 4.13M | 4.13M | 2.35M | 1.17M | 50.47M | 49.45M | 49.47M | 49.52M | 50.74M | 61.88M | 102.26M | 79.90M | 151.16M | |||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 29.04M | 30.16M | 30.11M | 33.06M | 32.57M | 32.43M | 32.67M | 37.31M | 41.03M | 45.81M | 42.70M | 50.75M | 49.95M | 49.47M | 50.01M | 50.01M | 61.88M | 61.88M | 61.88M | 151.16M | |||||||||||
| EBITDA | -11.14M | -11.56M | -13.89M | -13.00M | -13.06M | -11.78M | -16.30M | -16.96M | -15.89M | -18.67M | -23.15M | -28.03M | -30.28M | -33.05M | -33.78M | -37.14M | -45.91M | -46.59M | -42.61M | -52.02M | |||||||||||
| Interest ExpensesInt Expense | 0.75M | 0.29M | 0.57M | 0.58M | 0.56M | 0.52M |